Shekman Wong

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia

Andrew W. Roberts, Matthew S. Davids, John M. Pagel et al. · New England Journal of Medicine · 2015 · 1.9K citations · Full text

Medicine, Cancer Biology, Oncology +14

Management of Venetoclax-Posaconazole Interaction in Acute Myeloid Leukemia Patients: Evaluation of Dose Adjustments

Suresh Agarwal, Courtney D. DiNardo, Jalaja Potluri et al. · Clinical Therapeutics · 2017 · 232 citations

Medicine, Pharmacology, Pharmacotherapy +11

Microdialysis Calibration Using Retrodialysis and Zero-Net Flux: Application to a Study of the Distribution of Zidovudine to Rabbit Cerebrospinal Fluid and Thalamus

Yanfeng Wang, Shekman Wong, Ronald J. Sawchuk · Pharmaceutical Research · 1993 · 176 citations

Life Sciences, Neuroscience, Physiology +3

Discovery of <i>N</i>-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor

Keith F. McDaniel, Le Wang, Todd Soltwedel et al. · Journal of Medicinal Chemistry · 2017 · 137 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Pharmacokinetics of Venetoclax, a Novel BCL‐2 Inhibitor, in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Non‐Hodgkin Lymphoma

Ahmed Hamed Salem, Suresh Agarwal, Martin Dunbar et al. · The Journal of Clinical Pharmacology · 2016 · 133 citations

Medicine, Pharmacokinetics, Pharmacology +14